APA (7th ed.) Citation

Zhang N, Zhang C, Zeng Z, Zhang J, Du S, Bao C, & Wang Z. (2021). Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis. Dove Medical Press.

Chicago Style (17th ed.) Citation

Zhang N, Zhang C, Zeng Z, Zhang J, Du S, Bao C, and Wang Z. Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis. Dove Medical Press, 2021.

MLA (9th ed.) Citation

Zhang N, et al. Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis. Dove Medical Press, 2021.